共 50 条
- [21] Single-Agent Rituximab for Primary CNS Lymphoma During Pregnancy As a Bridge to Definitive ManagementJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (07) : E14 - E17Burnette, Brian L.Jentoft, Mark A.Porrata, Luis F.Boyce, Thomas G.Witzig, Thomas E.
- [22] Phase II trial of recurrent primary CNS lymphoma (PCNSL) treated with pemetrexedJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Altman, J. K.Tellez, C.Chandler, J.Levy, R. M.Getch, C.Cohn, R.Gallot, L.Marymont, M.Grimm, S. A.Raizer, J. J.
- [23] Single institution retrospective review of patients with primary CNS lymphoma (PCNSL).JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Johnson, Andrew ThomasNooruddin, ZohraKing, Gentry TengSchade, Henning HelmutKamdar, Manali K.Haverkos, Brad M.Ney, Douglas Edward
- [24] Relapse of Central Nervous System Lymphoma after systemic Lymphoma (SCNSL): Clinical Features and Outcome as compared to Primary CNS Lymphoma (PCNSL) Patients.BLOOD, 2008, 112 (11) : 1232 - 1232Schmidt-Wolf, IngoPels, HendrikJuergens, AnnikaPatrij, KatrinWaetzel, LuiseHerrlinger, UlrichSchulz, HolgerEngert, AndreasLinnebank, MichaelSchackert, GabrieleReichmann, HeinzKroschinsky, FrankVogt-Schaden, MarliesEgerer, GertlindeSchaller, CarloLamprecht, MonikaHau, PeterDeckert, MartinFimmers, RolfBangard, ChristophReiser, Marcel
- [25] Is single-agent temozolomide the treatment of choice for recurrent primary central nervous system lymphoma?NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (09): : 514 - 515Omuro, Antonio Mp
- [26] Is single-agent temozolomide the treatment of choice for recurrent primary central nervous system lymphoma?Nature Clinical Practice Oncology, 2007, 4 : 514 - 515Antonio MP Omuro
- [27] A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)NEURO-ONCOLOGY, 2023, 25Chukwueke, UgonmaWright, IsobelMuzikansky, AlonaRuss, AlyssaFontana, BrittneyKats, VanessaO'Donnell, ColinScalfani, ReneeAcevedo-Naranjo, BrendaLee, EudociaCastro, Luis Nicolas GonzalezMcFaline-Figueroa, Jose RicardoAquilanti, ElisaYoussef, GilbertBeroukhim, RameenForst, DeborahReardon, DavidWen, PatrickBatchelor, TracyTorres, AlexandraStefanik, JenniferFisher, JenniferMeredith, DavidMurakami, MarkGarcia, YuriShipp, MargaretNayak, Lakshmi
- [28] Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphomaJOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 519 - 526O'Brien, PRoos, DPratt, GLiew, KBarton, MPoulsen, MOlver, ITrotter, G
- [29] Updated results from NABTT CNS consortium studies in primary CNS lymphomaANNALS OF ONCOLOGY, 2005, 16 : 125 - 125Batchelor, TGrossman, SCarson, KFisher, J
- [30] First Results of the Acse Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) CohortBLOOD, 2020, 136Hoang-Xuan, KheHouot, RochSoussain, CaroleBlonski, MarieSchmitt, AnnaDelwail, VincentDamaj, Gandhi LaurentGhesquieres, HervePeyrade, FredericTempescul, AdrianAbraham, JulieAgape, PhilippeAhle, GuidoBaize, NathalieBories, PierreCampello, ChantalGyan, EmmanuelJardin, FabriceRey, PhilippeChoquet, SylvainHouillier, CarolineCassoux, NathalieTouitou, ValerieMartin-Duverneuil, NadineLegrand, FredericLamrani-Ghaouti, AssiaQuerel, OphelieLabouret, Natalie HoogSimon, ClotildeChevret, SylvieMassard, Christophe